Abstract
Background: The demand for prenatal diagnosis (PD) of cystic fibrosis (CF) is increasing.
Methods: We performed pre-test multidisciplinary counselling for 192 couples at CF reproductive risk. In 11/192 (5.7%) cases PD was not performed mainly because counselling revealed a reproductive risk for atypical (mild) CF, while 181 PDs were performed in couples revealed at high risk for CF mainly because they already had a CF child (148/181, 81.8%) or had been identified through cascade screening (28/181, 15.5%).
Results: In 167/181 (92.3%) cases (including two dichorionic twin pregnancies), PD was performed on chorionic villi, and in 14 on amniocyte DNA. Only 1/181 PD was unsuccessful. In all other cases, single tandem repeat analysis excluded maternal contamination, and PD was made within 7 days of sampling. In total 116/180 (64.4%) PDs were made with dot-blot analysis; 40 (22.2%) required gene sequencing; in 4/180 cases we tested the gene for large rearrangements; in 23/180 (12.8%) cases linkage analysis was necessary because parental mutation(s) were unknown. Forty-two out of 180 (23.3%) PDs revealed an affected foetus. All couples but one interrupted pregnancy. The first twin PD revealed the absence (1 foetus) and the presence of one mutation (the other foetus); the second twin PD revealed one parental mutation (1 foetus) and both parental mutations (the other foetus); the couple planned selective interruption.
Conclusions: PD for CF should be performed in reference laboratories equipped for gene scanning and linkage analysis, with a multidisciplinary staff able to offer counselling to couples during all phases of PD.
Grants from Regione Campania (DGRC 1901/09 and L. 548/93, 2007 and 2010) and from Ministero della Salute (Ricerca finalizzata, annualità 2008) are gratefully acknowledged. We are indebted to Jean Ann Gilder (Scientific Communication srl, Naples, Italy) for editing the text.
Conflict of interest statement
Authors’ conflict of interest disclosure: The authors stated that there are no conflicts of interest regarding the publication of this article.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
References
1. Rosenstein BJ, Cutting GR. The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Consensus Panel. J Pediatr 1998;132:589–95.10.1016/S0022-3476(98)70344-0Search in Google Scholar PubMed
2. Bombieri C, Claustres M, De Boeck K, Derichs N, Dodge J, Girodon E, et al. Recommendations for the classification of diseases as CFTR-related disorders. J Cyst Fibrosis 2011;10:S86–102.10.1016/S1569-1993(11)60014-3http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000292068000014&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar
3. Tomaiuolo R, Spina M, Castaldo G. Molecular diagnosis of cystic fibrosis: comparison of four analytical procedures. Clin Chem Lab Med 2003;41:26–32.10.1515/CCLM.2003.006Search in Google Scholar PubMed
4. Castaldo G, Polizzi A, Tomaiuolo R, Cazeneuve C, Girodon E, Santostasi T, et al. Comprehensive cystic fibrosis mutation epidemiology and haplotype characterization in southern Italy population. Ann Hum Genet 2005;69:15–24.10.1046/j.1529-8817.2004.00130.xSearch in Google Scholar PubMed
5. Tomaiuolo R, Sangiuolo F, Bombieri C, Bonizzato A, Cardillo G, Raia V, et al. Epidemiology and a novel procedure for large scale analysis of CFTR rearrangements in classic and atypical CF patients: a multicentric Italian study. J Cyst Fibrosis 2008;7:347–51.10.1016/j.jcf.2007.12.004http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000259887500002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar
6. Giordano S, Amato F, Elce A, Monti M, Iannone C, Pucci P, et al. Molecular and functional analysis of the large 5’ promoter region of CFTR gene revealed pathogenic mutations in CF and CFTR-related disorders. J Mol Diagn 2013 doi: 10.1016/ j.jmoldx.2013.01.001. [Epub ahead of print]10.1016/j.jmoldx.2013.01.001.[Epubhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000318755200006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar PubMed
7. Amato F, Seia M, Giordano S, Elce A, Zarrilli F, Castaldo G, et al. Gene mutation in MicroRNA target sites of CFTR gene: a novel pathogenetic mechanism in cystic fibrosis? PLoS ONE 2013 8(3): e60448. doi:10.1371/journal.pone.0060448.Search in Google Scholar PubMed
8. Amato F, Bellia C, Cardillo G, Castaldo G, Ciaccio M, Elce A, et al. Extensive molecular analysis of patients bearing CFTR-related disorders. J Mol Diagn 2012;14:81–9.10.1016/j.jmoldx.2011.09.001http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000298571100011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar PubMed
9. Castaldo G, Martinelli P, Massa C, Fuccio A, Grosso M, Rippa E, et al. Prenatal diagnosis of cystic fibrosis: a case of twin pregnancy diagnosis and a review of 5 years’ experience [review]. Clin Chim Acta 2000;298:121–33.10.1016/S0009-8981(00)00284-9Search in Google Scholar
10. Castaldo G, Fuccio A, Salvatore D, Raia V, Santostasi T, Leonardi S, et al. Liver expression in cystic fibrosis could be modulated by genetic factors different from the Cystic Fibrosis Transmembrane Regulator genotype. Am J Med Genet 2001;98:294–7.10.1002/1096-8628(20010201)98:4<294::AID-AJMG1097>3.0.CO;2-KSearch in Google Scholar PubMed
11. De Braekeleer M, Rault G, Bellis G. Reproductive attitudes of couples having a child with cystic fibrosis in Brittany (France). J Hum Genet 2004;49:285–9.10.1007/s10038-004-0147-2Search in Google Scholar PubMed
12. Scotet V, Dugueperoux I, Audrezet MP, Blayau M, Boisseau P, Journel H, et al. Prenatal diagnosis of cystic fibrosis: the 18-year experience of Brittany (western France). Prenat Diagn 2008;28:197–202.10.1002/pd.1910Search in Google Scholar PubMed
13. Salvatore F. Multidisciplinarity and interdisciplinarity at work: the prenatal diagnosis. Editorial. Clin Chem Lab Med 2013;51: 2209–10.Search in Google Scholar
14. Maruotti GM, Frisso G, Calcagno G, Fortunato G, Castaldo G, Martinelli P, et al. Prenatal diagnosis of inherited diseases: the 20 years’ experience of an Italian Regional Reference Centre. Clin Chem Lab Med 2013;51:2011–7.10.1515/cclm-2013-0194Search in Google Scholar PubMed
15. Bruno F, Damin F, Causarano V, Galbiati S, Di Carlo G, Seia M, et al. High-sensitive microarray substrates specifically designed to improve sensitivity for the identification of fetal paternally inherited sequences in maternal plasma. Clin Chem Lab Med 2009;47:818–23.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000267978900006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar PubMed
16. Elce A, Boccia A, Cardillo G, Giordano S, Tomaiuolo R, Paolella G, et al. Three novel CFTR polymorphic repeats improve segregation analysis for cystic fibrosis. Clin Chem 2009;55:1372–9.10.1373/clinchem.2008.119545http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000267460200018&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar PubMed
17. Castaldo G, Fuccio A, Cazeneuve C, Picci L, Salvatore D, Raia V, et al. Detection of five rare cystic fibrosis mutations peculiar to Southern Italy: implications in screening for the disease and phenotype characterization for patients with CFTR homozygote mutations. Clin Chem 1999;45:957–62.10.1093/clinchem/45.7.957Search in Google Scholar PubMed
18. Castaldo G, Rippa E, Sebastio G, Raia V, Ercolini P, De Ritis G, et al. Molecular epidemiology of cystic fibrosis mutations and haplotypes in southern Italy evaluated with an improved semiautomated robotic procedure. J Med Genet 1996;33:475–9.10.1136/jmg.33.6.475Search in Google Scholar PubMed PubMed Central
19. Tomaiuolo R, Fausto M, Elce A, Strina I, Ranieri A, Amato F, et al. Enhanced frequency of CFTR gene variants in coupled who are candidates for assisted reproductive technology treatment. Clin Chem Lab Med 2011;49:1289–93.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000293561900008&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.1515/CCLM.2011.637Search in Google Scholar PubMed
20. Dequeker E, Stuhrmann M, Morris MA, Casals T, Castellani C, Claustres M, et al. Best practice guidelines for molecular genetic diagnosis of cystic fibrosis and -related disorders – updated European recommendations. Eur J Hum Genet 2009;17:51–65.10.1038/ejhg.2008.136Search in Google Scholar PubMed PubMed Central
21. Rantanen E, Hietala M, Kristoffersson U, Nippert I, Schmidtke J, Sequeiros J, et al. Regulations and practices of genetic counselling in 38 European countries: the perspective of national representatives. Eur J Hum Genet 2008;16:1208–16.10.1038/ejhg.2008.93http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000259502200011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar PubMed
22. Winsor EJ, Akoury H, Chitayat D, Steele L, Stockley TL. The role of molecular microsatellite identity testing to detect sampling errors in prenatal diagnosis. Prenat Diagn 2010;30:746–52.10.1002/pd.2530http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000280897300006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar PubMed
23. Rendine S, Calafell F, Cappello N, Gagliardini R, Caramia G, Rigillo N, et al. Genetic history of cystic fibrosis mutations in Italy. I. Regional distribution. Ann Hum Genet 1997;61:411–24.10.1017/S0003480097006477Search in Google Scholar PubMed
24. Castaldo G, Lembo F, Tomaiuolo R. Molecular diagnostics: between chips and customized medicine. Clin Chem Lab Med 2010;48:973–82.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000279341900011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Search in Google Scholar PubMed
25. Taruscio D, Falbo V, Floridia G, Salvatore M, Pescucci C, Cantafora A, et al. Quality assessment in cytogenetic and molecular genetic testing: the experience of the Italian project on standardisation and quality assurance. Clin Chem Lab Med 2004;42:915–21.10.1515/CCLM.2004.148Search in Google Scholar PubMed
©2013 by Walter de Gruyter Berlin Boston
